Complicated [Design Issues]

posted by ElMaestro  – Denmark, 2010-06-07 20:28 (5015 d 03:52 ago) – Posting: # 5459
Views: 8,035

Dear ioanam,

This is a tricky situation. I would encourage you to (ask the man with the money to) seek scientific advise or whatever equivalent is available if your target market is not Europe. You have a complicated drug, complicated info on the ref SPC, and you need to tiptoe through an ethical mine field.

I agree with HS, that a parallel study in patients is likely to be the way to do it.

Best regards
EM.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,916 posts in 4,807 threads, 1,646 registered users;
27 visitors (0 registered, 27 guests [including 6 identified bots]).
Forum time: 23:21 CET (Europe/Vienna)

Nothing shocks me. I’m a scientist.    Harrison Ford (as Indiana Jones)

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5